<DOC>
<DOCNO>
EP-0001845
</DOCNO>
<TEXT>
<DATE>
19790516
</DATE>
<IPC-CLASSIFICATIONS>
C07K-5/00 C07K-5/097 C07K-1/113 A61P-25/00 C07K-14/435 C07K-1/00 C07K-14/575 A61P-25/26 A61K-38/00 C07K-5/08 
</IPC-CLASSIFICATIONS>
<TITLE>
analeptic tripeptides, process for their preparation and pharmaceutical composition containing the same
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>
</APPLICANT>
<INVENTOR>
hirschmann ralph franzus <sep>nutt ruth foelsche us<sep>veber daniel frankus<sep>hirschmann, ralph franz<sep>nutt, ruth foelsche<sep>veber, daniel frank<sep>hirschmann, ralph franz740 palmer placeblue bell pennsylvania 19422us<sep>nutt, ruth foelschehill road rd 1green lane pennsylvania 18054us<sep>veber, daniel frank290 batleson roadambler pennsylvania 19002us<sep>
</INVENTOR>
<ABSTRACT>
novel tripeptides related to thyrotropin releasing hormone, with methylprolineamide or methylthioprolineamide as the c-terminal amino acid, are stimulants of the central nervous system.  they are preparable by standard peptide synthetic procedures. 
</ABSTRACT>
</TEXT>
</DOC>
